Thymoglobulin
Payments companies reported to CMS as associated with Thymoglobulin. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Thymoglobulin, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Thymoglobulin
These are the largest totals companies reported as associated with Thymoglobulin. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dorry Segev | Baltimore, MD | Surgery | $471,835.08 |
| Jason Wellen | Saint Louis, MO | Transplant Surgery | $91,184.85 |
| Suphamai Bunnapradist | Los Angeles, CA | Nephrology (Internal Medicine) | $90,320.92 |
| Ervin Woodle | Cincinnati, OH | Transplant Surgery | $79,312.19 |
| Michael Marvin | Danville, PA | Transplant Surgery | $65,366.68 |
| Michael Goldstein | Hackensack, NJ | Transplant Surgery | $59,204.51 |
| Matthew Cooper | Milwaukee, WI | Transplant Surgery | $55,522.16 |
| Daniel Brennan | Baltimore, MD | Nephrology (Internal Medicine) | $51,555.31 |
| Krista Lentine | Saint Louis, MO | Nephrology (Internal Medicine) | $47,284.73 |
| Christina Klein | Atlanta, GA | Nephrology (Internal Medicine) | $46,133.45 |
Prescribed Thymoglobulin?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.